Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Resistance to malaria through structural variation of red blood cell invasion receptors.

Leffler EM, Band G, Busby GBJ, Kivinen K, Le QS, Clarke GM, Bojang KA, Conway DJ, Jallow M, Sisay-Joof F, Bougouma EC, Mangano VD, Modiano D, Sirima SB, Achidi E, Apinjoh TO, Marsh K, Ndila CM, Peshu N, Williams TN, Drakeley C, Manjurano A, Reyburn H, Riley E, Kachala D, Molyneux M, Nyirongo V, Taylor T, Thornton N, Tilley L, Grimsley S, Drury E, Stalker J, Cornelius V, Hubbart C, Jeffreys AE, Rowlands K, Rockett KA, Spencer CCA, Kwiatkowski DP; Malaria Genomic Epidemiology Network.

Science. 2017 Jun 16;356(6343). pii: eaam6393. doi: 10.1126/science.aam6393. Epub 2017 May 18.

2.

Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.

Clarke GM, Rockett K, Kivinen K, Hubbart C, Jeffreys AE, Rowlands K, Jallow M, Conway DJ, Bojang KA, Pinder M, Usen S, Sisay-Joof F, Sirugo G, Toure O, Thera MA, Konate S, Sissoko S, Niangaly A, Poudiougou B, Mangano VD, Bougouma EC, Sirima SB, Modiano D, Amenga-Etego LN, Ghansah A, Koram KA, Wilson MD, Enimil A, Evans J, Amodu OK, Olaniyan S, Apinjoh T, Mugri R, Ndi A, Ndila CM, Uyoga S, Macharia A, Peshu N, Williams TN, Manjurano A, Sepúlveda N, Clark TG, Riley E, Drakeley C, Reyburn H, Nyirongo V, Kachala D, Molyneux M, Dunstan SJ, Phu NH, Quyen NN, Thai CQ, Hien TT, Manning L, Laman M, Siba P, Karunajeewa H, Allen S, Allen A, Davis TM, Michon P, Mueller I, Molloy SF, Campino S, Kerasidou A, Cornelius VJ, Hart L, Shah SS, Band G, Spencer CC, Agbenyega T, Achidi E, Doumbo OK, Farrar J, Marsh K, Taylor T, Kwiatkowski DP; MalariaGEN Consortium.

Elife. 2017 Jan 9;6. pii: e15085. doi: 10.7554/eLife.15085.

3.

Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial.

Kremsner PG, Adegnika AA, Hounkpatin AB, Zinsou JF, Taylor TE, Chimalizeni Y, Liomba A, Kombila M, Bouyou-Akotet MK, Mawili Mboumba DP, Agbenyega T, Ansong D, Sylverken J, Ogutu BR, Otieno GA, Wangwe A, Bojang KA, Okomo U, Sanya-Isijola F, Newton CR, Njuguna P, Kazungu M, Kerb R, Geditz M, Schwab M, Velavan TP, Nguetse C, Köhler C, Issifou S, Bolte S, Engleitner T, Mordmüller B, Krishna S.

PLoS Med. 2016 Jan 12;13(1):e1001938. doi: 10.1371/journal.pmed.1001938. eCollection 2016 Jan.

4.

Heterogeneous alleles comprising G6PD deficiency trait in West Africa exert contrasting effects on two major clinical presentations of severe malaria.

Shah SS, Rockett KA, Jallow M, Sisay-Joof F, Bojang KA, Pinder M, Jeffreys A, Craik R, Hubbart C, Wellems TE, Kwiatkowski DP; MalariaGEN Consortium.

Malar J. 2016 Jan 7;15:13. doi: 10.1186/s12936-015-1045-0.

5.

Changes in malaria parasite drug resistance in an endemic population over a 25-year period with resulting genomic evidence of selection.

Nwakanma DC, Duffy CW, Amambua-Ngwa A, Oriero EC, Bojang KA, Pinder M, Drakeley CJ, Sutherland CJ, Milligan PJ, Macinnis B, Kwiatkowski DP, Clark TG, Greenwood BM, Conway DJ.

J Infect Dis. 2014 Apr 1;209(7):1126-35. doi: 10.1093/infdis/jit618. Epub 2013 Nov 21.

6.

Seroepidemiological and parasitological evaluation of the heterogeneity of malaria infection in the Gambia.

Oduro AR, Conway DJ, Schellenberg D, Satoguina J, Greenwood BM, Bojang KA.

Malar J. 2013 Jul 1;12:222. doi: 10.1186/1475-2875-12-222.

7.

Sahel, savana, riverine and urban malaria in West Africa: Similar control policies with different outcomes.

Ceesay SJ, Bojang KA, Nwakanma D, Conway DJ, Koita OA, Doumbia SO, Ndiaye D, Coulibaly TF, Diakité M, Traoré SF, Coulibaly M, Ndiaye JL, Sarr O, Gaye O, Konaté L, Sy N, Faye B, Faye O, Sogoba N, Jawara M, Dao A, Poudiougou B, Diawara S, Okebe J, Sangaré L, Abubakar I, Sissako A, Diarra A, Kéita M, Kandeh B, Long CA, Fairhurst RM, Duraisingh M, Perry R, Muskavitch MA, Valim C, Volkman SK, Wirth DF, Krogstad DJ.

Acta Trop. 2012 Mar;121(3):166-74. doi: 10.1016/j.actatropica.2011.11.005. Epub 2011 Nov 19.

8.

Health centre surveys as a potential tool for monitoring malaria epidemiology by area and over time.

Oduro AR, Bojang KA, Conway DJ, Corrah T, Greenwood BM, Schellenberg D.

PLoS One. 2011;6(11):e26305. doi: 10.1371/journal.pone.0026305. Epub 2011 Nov 4.

9.

Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial.

Bojang KA, Akor F, Conteh L, Webb E, Bittaye O, Conway DJ, Jasseh M, Wiseman V, Milligan PJ, Greenwood B.

PLoS Med. 2011 Feb 1;8(2):e1000409. doi: 10.1371/journal.pmed.1000409.

10.

A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The Gambia.

Sesay S, Milligan P, Touray E, Sowe M, Webb EL, Greenwood BM, Bojang KA.

Malar J. 2011 Jan 7;10:2. doi: 10.1186/1475-2875-10-2.

11.

Continued decline of malaria in The Gambia with implications for elimination.

Ceesay SJ, Casals-Pascual C, Nwakanma DC, Walther M, Gomez-Escobar N, Fulford AJ, Takem EN, Nogaro S, Bojang KA, Corrah T, Jaye MC, Taal MA, Sonko AA, Conway DJ.

PLoS One. 2010 Aug 18;5(8):e12242. doi: 10.1371/journal.pone.0012242.

12.

Prevention of the recurrence of anaemia in Gambian children following discharge from hospital.

Bojang KA, Milligan PJ, Conway DJ, Sisay-Joof F, Jallow M, Nwakanma DC, Abubakr I, Njie F, Greenwood B.

PLoS One. 2010 Jun 21;5(6):e11227. doi: 10.1371/journal.pone.0011227.

13.

A decline in the incidence of invasive non-typhoidal Salmonella infection in The Gambia temporally associated with a decline in malaria infection.

Mackenzie G, Ceesay SJ, Hill PC, Walther M, Bojang KA, Satoguina J, Enwere G, D'Alessandro U, Saha D, Ikumapayi UN, O'Dempsey T, Mabey DC, Corrah T, Conway DJ, Adegbola RA, Greenwood BM.

PLoS One. 2010 May 11;5(5):e10568. doi: 10.1371/journal.pone.0010568.

14.

Genome-wide and fine-resolution association analysis of malaria in West Africa.

Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, Clark TG, Kivinen K, Bojang KA, Conway DJ, Pinder M, Sirugo G, Sisay-Joof F, Usen S, Auburn S, Bumpstead SJ, Campino S, Coffey A, Dunham A, Fry AE, Green A, Gwilliam R, Hunt SE, Inouye M, Jeffreys AE, Mendy A, Palotie A, Potter S, Ragoussis J, Rogers J, Rowlands K, Somaskantharajah E, Whittaker P, Widden C, Donnelly P, Howie B, Marchini J, Morris A, SanJoaquin M, Achidi EA, Agbenyega T, Allen A, Amodu O, Corran P, Djimde A, Dolo A, Doumbo OK, Drakeley C, Dunstan S, Evans J, Farrar J, Fernando D, Hien TT, Horstmann RD, Ibrahim M, Karunaweera N, Kokwaro G, Koram KA, Lemnge M, Makani J, Marsh K, Michon P, Modiano D, Molyneux ME, Mueller I, Parker M, Peshu N, Plowe CV, Puijalon O, Reeder J, Reyburn H, Riley EM, Sakuntabhai A, Singhasivanon P, Sirima S, Tall A, Taylor TE, Thera M, Troye-Blomberg M, Williams TN, Wilson M, Kwiatkowski DP; Wellcome Trust Case Control Consortium; Malaria Genomic Epidemiology Network.

Nat Genet. 2009 Jun;41(6):657-65. doi: 10.1038/ng.388. Epub 2009 May 24.

15.

Novel therapies for the prevention of malaria.

Bojang KA.

Expert Opin Investig Drugs. 2008 Dec;17(12):1839-47. doi: 10.1517/13543780802514039 . Review.

PMID:
19012500
16.

Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis.

Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJ, Sesay SS, Abubakar I, Dunyo S, Sey O, Palmer A, Fofana M, Corrah T, Bojang KA, Whittle HC, Greenwood BM, Conway DJ.

Lancet. 2008 Nov 1;372(9649):1545-54. doi: 10.1016/S0140-6736(08)61654-2.

17.

Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection.

Polley SD, Tetteh KK, Lloyd JM, Akpogheneta OJ, Greenwood BM, Bojang KA, Conway DJ.

J Infect Dis. 2007 Jan 15;195(2):279-87. Epub 2006 Dec 13.

PMID:
17191173
18.

RTS,S/AS02A for malaria.

Bojang KA.

Expert Rev Vaccines. 2006 Oct;5(5):611-5. Review.

PMID:
17181435
19.

Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children.

Bojang KA, Olodude F, Pinder M, Ofori-Anyinam O, Vigneron L, Fitzpatrick S, Njie F, Kassanga A, Leach A, Milman J, Rabinovich R, McAdam KP, Kester KE, Heppner DG, Cohen JD, Tornieporth N, Milligan PJ.

Vaccine. 2005 Jul 14;23(32):4148-57. Epub 2005 Apr 15.

PMID:
15964483
20.

Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria.

Metzger WG, Okenu DM, Cavanagh DR, Robinson JV, Bojang KA, Weiss HA, McBride JS, Greenwood BM, Conway DJ.

Parasite Immunol. 2003 Jun;25(6):307-12.

21.

Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria.

Polley SD, Tetteh KK, Cavanagh DR, Pearce RJ, Lloyd JM, Bojang KA, Okenu DM, Greenwood BM, McBride JS, Conway DJ.

Infect Immun. 2003 Apr;71(4):1833-42.

22.

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.

Bojang KA, Milligan PJ, Pinder M, Vigneron L, Alloueche A, Kester KE, Ballou WR, Conway DJ, Reece WH, Gothard P, Yamuah L, Delchambre M, Voss G, Greenwood BM, Hill A, McAdam KP, Tornieporth N, Cohen JD, Doherty T; RTS, S Malaria Vaccine Trial Team.

Lancet. 2001 Dec 8;358(9297):1927-34.

PMID:
11747915
23.

Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays.

Flanagan KL, Lee EA, Gravenor MB, Reece WH, Urban BC, Doherty T, Bojang KA, Pinder M, Hill AV, Plebanski M.

J Immunol. 2001 Oct 15;167(8):4729-37.

24.

A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses.

Conway DJ, Cavanagh DR, Tanabe K, Roper C, Mikes ZS, Sakihama N, Bojang KA, Oduola AM, Kremsner PG, Arnot DE, Greenwood BM, McBride JS.

Nat Med. 2000 Jun;6(6):689-92.

PMID:
10835687
25.

A prospective evaluation of a clinical algorithm for the diagnosis of malaria in Gambian children.

Bojang KA, Obaro S, Morison LA, Greenwood BM.

Trop Med Int Health. 2000 Apr;5(4):231-6.

27.

A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children.

Bojang KA, Schneider G, Forck S, Obaro SK, Jaffar S, Pinder M, Rowley J, Greenwood BM.

Trans R Soc Trop Med Hyg. 1998 Jan-Feb;92(1):73-6.

PMID:
9692160
28.

An efficacy trial of the malaria vaccine SPf66 in Gambian infants--second year of follow-up.

Bojang KA, Obaro SK, D'Alessandro U, Bennett S, Langerock P, Targett GA, Greenwood BM.

Vaccine. 1998 Jan;16(1):62-7.

PMID:
9607010
29.

Predictors of mortality in Gambian children with severe malaria anaemia.

Bojang KA, Van Hensbroek MB, Palmer A, Banya WA, Jaffar S, Greenwood BM.

Ann Trop Paediatr. 1997 Dec;17(4):355-9.

PMID:
9578796
30.

Management of severe malarial anaemia in Gambian children.

Bojang KA, Palmer A, Boele van Hensbroek M, Banya WA, Greenwood BM.

Trans R Soc Trop Med Hyg. 1997 Sep-Oct;91(5):557-61.

PMID:
9463667
31.

Follow-up of Gambian children recruited to a pilot safety and immunogenicity study of the malaria vaccine SPf66.

Bojang KA, Obaro SK, Leach A, D'Alessandro U, Bennett S, Metzger W, Ballou WR, Targett GA, Greenwood BM.

Parasite Immunol. 1997 Dec;19(12):579-81.

Supplemental Content

Loading ...
Support Center